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Among 756 premenopausal women who underwent diagnos-
tic mammography between November 2015 and March 2016,
171 of these premenopausal women enrolled in this prospective
study. Clinical indication for mammography was either routine
screening mammography for women with no presenting com-
plaints or diagnostic mammography for women with suspiciousby the Medipol University Ethics Committee and all subjects
Objective
Epicardial fat tissue (EFT) is located between myocardium and
visceral pericardium. It has the same embryologic origin with the mes-
enteric omental fat tissue. It is very close to themyocardium and shares
the samemicrocirculation.1 EFT functions as amechanical buffer against
coronary arterial wave torsion, plays an important role in maintaining
fatty acid homeostasis and is thought to contribute coronary artery
remodelling.2 EFT secretes several proinﬂammatory cytokines such
as angiotensin II, tumor necrosis factor-α, monocyte chemotactic
protein-1, interleukin-6, resistin and plays an active role in inﬂammatory
and atherosclerotic processes.3,4
Breast arterial calciﬁcations (BAC) are a type of medial calciﬁca-
tion detected at mammography. Its prevalence ranges between 1%
and 49% in female population.5 Age, race and ethnicity are the most
important factors inﬂuencing the prevalence of BAC.6 BAC have
been associated with hypertension,7 diabetes mellitus,7 coronary ar-
tery disease8 and are a risk marker for future cardiovascular disease
events.9 Women with mammography-detected BAC are more likely
to have coronary artery calciﬁcation which is an early sign of coro-
nary artery disease.10
In this study starting with the possibility of existence of correlation
between EFT thickness and BAC, we aimed to investigate the relation-
ship between EFT thickness and BAC in premenopausal women.Aksalur cad, Oyak sitesi sok, 38
drmelik@hotmail.com
diovascular Academy.
. Production andhosting by Elsevierﬁndings on breast ultrasound. The study protocol was approved
gave informed consent prior to participation. The study group
consisted of 80 women with mammography detected BAC and
the control group consisted of 86 women without BAC (an exam-
ple of BAC is shown in Fig. 1.) Women with hypertension, diabetes
mellitus, hyperlipidemia, ischemic heart disease, congestive
heart failure, thyroid dysfunction, anemia, renal or hepatic fail-
ure, stroke or other chronic medical disorders were excluded
from the study.
Blood samples were collected from antecubital vein after an over-
night fast. Serum total cholesterol (TC), triglycerides (TG), high-density
lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol
(LDL-C), fasting glucose were analysed.
Each subject underwent a full-ﬁeld digital mammographic examina-
tion using aMammomat 3000Nova equipment (Siemens AG, Germany).
All mammograms had craniocaudal and mediolateral oblique images
of the two breasts. All images were interpreted by an experienced radi-
ologist who was blinded to the echocardiography results. BAC were
described as deposits of parallel lines of calcium when the arterial wall
was imaged longitudinally or as calciﬁc rings when the arterial wall
was imaged transversely.11
All the subjects underwent full transthoracic echocardiographic ex-
amination using Vivid 3 pro (GE Vingmed Ultrasound AS, Horten,
Norway) in accordance with the recommendations of the American
Society of Echocardiograpy.12 Left ventricular ejection fraction (LVEF)
wasmeasured by using Simpson rule. Epicardial fat tissuewas identiﬁed
as echo free space between myocardium and visceral pericardium and
its thickness was measured perpendicularly on the free wall of right
ventricle fromparasternal long-axis and short axis views at end diastole
by an experienced cardiologist who was blinded to the clinical results
of the patients.13 The average of three measurements was used for
statistical analysis.B.V. This is an open access article under the CCBY-NC-ND license (http://creativecommons.
Fig. 1. An example of BAC.
Table 1
Clinical and biochemical parameters of the patients.
Study group
(n = 80)
Control group
(n = 86)
P
Age 44.7 ± 3.7 45.1 ± 3.3 0.36
Height (m) 1.64 ± 0.08 1.65 ± 0.07 0.37
Weight (kg) 74.3 ± 10.7 72.8 ± 9.2 0.33
BMI 27.8 ± 5.1 26.8 ± 4.1 0.16
Smokers, n (%) 15 (18) 18 (20.4) 0.44
Alcohol, n (%) 8 (9.6) 9 (10.2) 0.57
Fasting Glucose (mg/dl) 99.7 ± 10.3 96.9 ± 8.3 0.06
TC (mg/dl) 190.7 ± 36.7 188.3 ± 26.6 0.64
LDL-C (mg/dl) 133.7 ± 25.9 125.1 ± 27.8 0.04
HDL-C (mg/dl) 43.4 ± 9.8 41.8 ± 9.9 0.30
TG (mg/dl) 157.2 ± 58.9 156.6 ± 59.3 0.94
SBP (mmHg) 131.4 ± 11.6 130.1 ± 18.2 0.59
DBP (mmHg) 81.8 ± 8.7 82.3 ± 8.1 0.72
LVEF (%) 62.7 ± 4.1 63.3 ± 3.5 0.36
EFT thickness (mm) 3.65 ± 0.73 2.94 ± 0.67 b0.001
TC: Total cholesterol; LDL-C: Low density lipoprotein cholesterol; HDL-C:High density
lipoprotein cholesterol; TG: Triglyceride; SBP: Systolic blood pressure DBP: Diastolic
blood pressure; LVEFF: Left ventricular ejection fraction; EFT: Epicardial Fat tissue.
Table 2
Parameters that have associations with BAC.
OR 95% C.I. P
TC 0.962 0.938–0.986 0.002
LDL-C 0.955 0.924–0.987 0.007
BMI 0.631 0.510–0.782 b0.001
EFT thickness 869.4 97.91–7719.8 b0.001
BAC: Breast arterial calciﬁcations; BMI: Body mass index; TC: Total cholesterol; LDL-C:
Low density lipoprotein cholesterol; HDL-C: High density lipoprotein cholesterol; TG:
Triglyceride.
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Continuous variables were expressed as mean and standard devia-
tion. Categorical variables were expressed as percentages. Parametric
continuous variables and categorical variables were compared by
Student's t-test and, the chi square test respectively. Multiple regression
analysis was used to evaluate the possible associations of weight, BMI,
glucose, LDL-C, HDL\\C, TC, TG, EFT with BAC. P values b0.05 were con-
sidered signiﬁcant. All statistical studies were carried out by using the
SPSS program (version 15.0; SPSS Inc., Chicago, Illinois, USA).
Results
Among 756womenwhounderwent screening and diagnosticmam-
mography, 168 subjects met the entry criteria and were enrolled in the
study. 80 women with BAC were accepted as the study group, and 86
womenwithout BAC were accepted as the control group. No signiﬁcant
difference was detected between the two groups with respect to age,
weight, height, BMI, LVEF, fasting glucose, TC, HDL-C and TG levels.
LDL-C level and EFT thickness were statistically signiﬁcantly higher in
the study group compared to the control group (3.65 ± 0.73 mm vs.
2.94 ± 0.67 mm, p b 0.001, respectively). Clinical and biochemical
parameters of the patients are shown in Table 1.
Multiple regression analysis showed that EFT thickness, TC, LDL-C
and BMI were important associations of BAC (Table 2).
Discussion
Our study showed an association between EFT thickness and BAC
in patients without structural heart disease. EFT thickness was signiﬁ-
cantly higher in patients with BAC. There was a strong association
between EFT thickness and BAC. We also found positive associations
between EAT thickness and TC, BMI, LDL-C.
Anatomically EFT, located betweenmyocardium and visceral pericar-
dium, is mainly concentrated in the atrioventricular and interventriculargrooves and shares the samemicrocirculationwith themyocardium and
coronary arteries.14 EFT has paracrine and vasocrine activities, have both
harmful and protective effects on heart through release of variety of
adipocytokines.15 Recently, it has been demonstrated that increased
EFT thickness occurs with disorders such as hypertension,.16insulin
resistance,17 metabolic syndrome,18 and coronary atherosclerosis.4
Several studies have assessed the relationship between EFT and coronary
artery disease.3,4,15,19 The pathophysiological mechanisms responsible
for CAD development through EFT are not clearly elucidated. In patients
with CAD, inﬂammatory pathways within EFT are activated and EFT
secretes more chemokines and cytokines that mediate inﬂammation.20
EFT may act as an endocrine organ by secreting various factors in the
circulation thus contributing coronary lesion formation.
Vascular calciﬁcations occur in the intima or media layers of the
vessel wall. Intimal calciﬁcation is almost always associated with ath-
erosclerosis, whereas BAC are a form of medial arterial sclerosis which
is independent of atherosclerosis.21,22 These two types of calciﬁcation
represent pathophysiological different mechanisms. Intimal calci-
ﬁcation is related to chronic inﬂammatory changes which involve
growth factors, inﬂammatory cells, lipid deposition and macrophage
accumulation.21 Medial arterial calciﬁcation is almost always associated
with aging, chronic renal failure or diabetes and involves the differ-
entiation of vascular smooth muscle cells into osteoblast like cells.22
BAC are correlated with subsequent development of coronary artery
calciﬁcations,23–25 Kemmeren et al. found that presence of BAC was
associated with a 30% and 90% increase in cardiovascular mortality in
non-diabetic and diabetic women, respectively.26 Rotter et al. showed
that mammographically detected BAC was associated with an in-
creased prevalence of cardiovascular risk factors and cardiovascular
morbidity.11 A recent studyhas shown that presence of BAC are stronger
risk factor than other cardiovascular risk factors such as diabetes, hyper-
tension and hyperlipidemia for coronary artery calciﬁcation.27
Until several decades ago, it had been thought that coronary artery
disease was primarily a man's disease. Today, it is recognised that this
159C. Yıldız et al. / International Journal of the Cardiovascular Academy 2 (2016) 157–159belief is not true, as cardiovascular disease is themost common cause of
death among women throughout the world; In addition cardiovascular
mortality rate among young women is still on the rise. Prevention and
diagnosis of coronary artery disease are of great importance, because
not only it increases the chances of cure, but it also reduces the major
complications that could be avoided at an early stage. Traditional risk
factors such as hyperlipidemia, hypertension, family history, diabetes
mellitus and smoking are commonly used to assess the cardiovascular
disease risk. Besides traditional risk factors, several new coronary risk
factors have been identiﬁed and play signiﬁcant roles in the atheroscle-
rosis development.28,29One of those risk factors is BAC. Recent studies
have shown that presence of BAC on mammograms indicates a greater
risk for coronary artery disease.27 As the EFT thickness was positively
correlated with BAC and LDL-C levels, risk factors for coronary artery
disease, in our study, EFT thickness measurement might play an impor-
tant role in coronary artery risk stratiﬁcation for premenopausalwomen
in clinical practice.
Study limitations
Visual scoring of conventional mammography was applied in BAC
assessment, the calciﬁcation mass scoring which is used at the digital
mammography was not performed.
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